Biomea Fusion, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMEA research report →
About the company
Biomea Fusion, Inc. is a biopharmaceutical firm dedicated to discovering and developing innovative covalent small molecule therapies. These treatments are specifically designed for individuals suffering from genetically defined cancers and various metabolic ailments.
- CEO
- Michael J. Hitchcock
- IPO
- 2021
- Employees
- 79
- HQ
- Redwood City, CA, US
Price Chart
- Market Cap
- $83.89M
- P/E
- -1.59
- P/S
- 0.00
- P/B
- 5.45
- EV/EBITDA
- -0.88
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -196.72%
- ROIC
- -173.69%
- Revenue
- $0 · 0.00%
- Net Income
- $-61,797,000 · 55.36%
- EPS
- $-1.18 · 69.19%
- Op Income
- $-81,307,000
- FCF YoY
- 41.48%
- 52W High
- $2.99
- 52W Low
- $0.87
- 50D MA
- $1.39
- 200D MA
- $1.44
- Beta
- -0.32
- Avg Volume
- 1.42M
Get TickerSpark's AI analysis on BMEA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 10, 26 | Faust Elizabeth | other | 196,299 |
| Jun 10, 26 | AGUIAR ERIC | other | 196,299 |
| Jun 10, 26 | Ray Sumita | other | 196,299 |
| Jun 10, 26 | Averill Julianne | other | 173,711 |
| Apr 1, 26 | Erdtmann Rainer M | other | 452,512 |
| Apr 1, 26 | Hitchcock Michael J.M. | other | 667,477 |
| Dec 31, 25 | Erdtmann Rainer M | other | 0 |
| Dec 31, 25 | Erdtmann Rainer M | other | 0 |
| Dec 11, 25 | Erdtmann Rainer M | buy | 30,000 |
| Dec 2, 25 | Hitchcock Michael J.M. | buy | 100,000 |
Our BMEA coverage
Recent articles, reports, and earnings notes.
No research on BMEA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BMEA report →Similar companies
Peers in the same neighborhood.